Q1 2026 DarioHealth Corp Earnings Call Transcript

May 13, 2026 / 12:30 PM GMT

Release Date Price: $8.1 (-6.68%)

Transcript 10-Q

Key Points

Positve

DarioHealth Corp (DRIO) reported its second consecutive quarter of sequential revenue growth, indicating positive financial momentum.
The company has successfully expanded its channel partnerships, now reaching over 175 million covered lives, which is expected to drive future revenue growth.
DarioHealth Corp (DRIO) is moving closer to care delivery, opening new revenue streams and enhancing its value proposition.
The company's proprietary AI engine, ValueIQ, has shown significant improvements in member engagement and retention, with up to 40% improvement in retention and 55% lift in active sessions.
DarioHealth Corp (DRIO) has a strong commercial pipeline, with approximately $127 million across 241 open opportunities, indicating robust future growth potential.

Negative

Despite revenue growth, DarioHealth Corp (DRIO) reported a year-over-year decline in revenue due to a strategic transition away from non-recurrent pharmaceutical revenue.
The company is still in the process of implementing large accounts signed in 2025, with revenue recognition expected primarily in the second half of 2026, indicating potential delays in revenue realization.
DarioHealth Corp (DRIO) continues to operate at a loss, with a non-GAAP operating loss of $5.3 million for the first quarter of 2026.
The transition to care delivery and outcomes-based models involves significant operational changes and partnerships, which may pose integration challenges.
The company's financial results are subject to numerous risks and uncertainties, including those related to its strategic review process and potential strategic transactions.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DRIO.OQ - DarioHealth Corp
Q1 2026 DarioHealth Corp Earnings Call
May 13, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen, and welcome to the Dario Health First Quarter 2026 Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. This call is being recorded on Wednesday, May 13, 2026. I would now like to turn the conference over to Zoe Harrison, VP Accounting and Corporate Development at Dario Health. Zoe, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning, everyone.

Thank you for joining us today for a discussion of Daria

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.